Based on the disparities observed in IL-16 levels and BFRs between the male and female sarcopenic patients in the patient and control groups, as well as the subsequent discussion on sarcopenic obesity in females, our study suggests a sex-specific variation in the pathogenesis of sarcopenia. The gene discussed is IL16; the disease is sarcopenia.